INmune Bio
Price & Volume
Stats
See moreOpen | $2.42 |
Previous Close | $2.43 |
Day Range | $2.40-$2.49 |
52W Range | $1.09-$2.48 |
Market Cap | $67.4M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 257.1% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.62 |
News
See moreYahoo Finance • 27 days ago
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
Yahoo Finance • 27 days ago
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
Yahoo Finance • 2 months ago
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
Yahoo Finance • 3 months ago
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
About
CEO | Mr. David J. Moss M.B.A. |
Address | 225 NE Mizner Blvd., Boca Raton, FL, United States, 33432 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |